한글목차

재택 약물 남용 검사 세계 시장은 2024년 6억 7,595만 달러에 달했고, 2030년까지 예측 기간 동안 연평균 5.01%의 강력한 성장세를 보일 것으로 예측됩니다.

이 시장은 약물 남용에 대한 인식 증가, 검사 기술의 지속적인 발전, 그리고 눈에 띄지 않는 가정 내 검사 옵션에 대한 수요 증가로 인해 빠르게 성장하고 있습니다. 이러한 자가 관리형 검사 키트는 사용자에게 약물 사용을 모니터링할 수 있는 개인적이고 편리한 방법을 제공하고, 임상 검사를 받을 필요를 없애줍니다. 이러한 솔루션에 대한 수요는 특히 약물 검사에서 비밀 보장을 중요시하는 개인들 사이에서 특히 강세를 보이고 있습니다.

시장은 지속적으로 성장하고 있지만, 가정용 검사 키트의 정확성과 신뢰성에 대한 우려는 여전히 남아있습니다. 검사 방법의 편차, 부적절한 시료 채취, 제한된 검출 능력 등의 문제로 인해 검사 결과가 일관되지 않아 위양성 및 위음성으로 이어질 수 있습니다. 이러한 부정확성은 특히 재활 치료를 받고 있거나 법적 절차에 관여하는 사람들에게 심각한 결과를 초래할 수 있습니다. 이에 제조업체들은 가정용 DOA 검사의 신뢰성과 유용성을 높이기 위해 검사 정확도 향상, 시료 채취 프로세스 개선, 검출 가능한 물질의 범위 확대에 주력하고 있습니다.

주요 시장 성장 촉진요인

주요 시장 과제:

주요 시장 동향 :

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 재택 약물 남용 검사 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 샘플 유형별(소변 검사, 타액 검사, 혈액 검사 등)
  • 제품 유형별(약물 검사 키트, 스트립/딥 카드, 카세트, 컵 등)
  • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
  • 기업별(2024년)
• 시장 맵
• 샘플 유형별
• 제품 유형별
• 지역별

제6장 북미의 재택 약물 남용 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 재택 약물 남용 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 재택 약물 남용 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 재택 약물 남용 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 재택 약물 남용 검사 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 인수합병(M&A)
• 제품 출시

제13장 세계의 재택 약물 남용 검사 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA.
• UCP Biosciences Inc.
• Orient New Life Medical Co. Ltd.
• Assure Tech.(Hangzhou) Co., LTD
• Psychemedics Corporation
• Confirm Biosciences Inc
• Pharmatech Inc.
• Atlas Medical GmbH
• Home Health(U.K.) Ltd.

제16장 전략적 제안

제17장 리서치사에 대해 & 면책사항

영문목차

Global At-Home Drug of Abuse Testing Market was valued at USD 675.95 million in 2024 and is expected to experience strong growth during the forecast period, with a compound annual growth rate (CAGR) of 5.01% through 2030. The market is expanding rapidly, driven by increasing awareness of substance abuse, ongoing advancements in testing technologies, and a growing demand for discreet, at-home screening options. These self-administered test kits offer users a private and convenient method to monitor drug use, eliminating the need for clinical visits. The demand for such solutions is particularly strong among individuals who value confidentiality in drug testing.

Despite the market's positive growth trajectory, concerns about the accuracy and reliability of at-home testing kits remain. Issues such as variations in testing methods, improper sample collection, and limited detection capabilities can result in inconsistent test results, leading to false positives or negatives. These inaccuracies can have serious consequences, especially for individuals undergoing rehabilitation or involved in legal proceedings. In response, manufacturers are focusing on enhancing test precision, improving sample collection processes, and expanding the range of detectable substances to enhance the credibility and usefulness of at-home DOA testing.

Key Market Drivers:

Prevalence of Substance Abuse: The widespread misuse of illicit and prescription drugs has created an increasing demand for frequent drug testing. In 2021, approximately 1 in 17 individuals aged 15-64 globally reported using a drug in the past year. The number of drug users rose from 240 million in 2011 to 296 million in 2021, accounting for 5.8% of the global population in this age group-a 23% increase. This trend has been driven in part by population growth and changing substance use patterns. The opioid crisis, particularly in North America, along with the growing legalization of cannabis in various regions, has raised concerns regarding workplace productivity, driving safety, and adolescent health. Additionally, the rising consumption of synthetic drugs, including methamphetamines and fentanyl analogs, has created a pressing need for cost-effective and rapid drug testing solutions. As a result, consumers and organizations are increasingly turning to at-home drug testing kits to identify substance use early and inform intervention or treatment decisions.

Key Market Challenges:

Accuracy and Reliability: Inaccurate test results, including false positives (indicating drug use when there is none) and false negatives (failing to detect drug use), can have significant consequences. These errors may lead to unnecessary panic or complacency, potentially undermining the credibility of at-home testing kits. If these tests are perceived as unreliable, consumers may lose confidence in the results, leading to reduced adoption rates. Inaccurate results can also influence critical decisions, such as treatment options or behavior changes, and may negatively impact legal cases or employment decisions. Unreliable test results can also harm the reputation of specific brands or the broader at-home drug testing market, resulting in negative word-of-mouth and potentially leading to stricter regulatory scrutiny. Ensuring consistent accuracy across various brands and batches presents an ongoing challenge for manufacturers, with quality control issues potentially affecting consumer perception.

Key Market Trends:

Advancements in Multi-Panel Testing Kits: Multi-panel testing kits, which detect multiple substances in a single test, are gaining traction due to their convenience and cost-effectiveness. By allowing users to screen for multiple drugs at once, these kits save time and reduce the need for separate tests. This efficiency is encouraging broader adoption and market growth. Moreover, multi-panel kits are often more affordable than purchasing individual tests for each drug, further boosting their popularity. These kits cover a wider range of substances, including common drugs of abuse and emerging drugs, thus meeting the diverse needs of users. They are especially appealing to parents concerned about their children's potential drug use, as well as to legal and clinical professionals who require more comprehensive information to make informed decisions. Public health campaigns promoting comprehensive drug testing align with the growing trend of multi-panel kits, further contributing to their widespread adoption.

Key Market Players

• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA.
• UCP Biosciences Inc.
• Orient New Life Medical Co. Ltd.
• Assure Tech. (Hangzhou) Co., LTD
• Psychemedics Corporation
• Confirm Biosciences Inc
• Pharmatech Inc.
• Atlas Medical GmbH
• Home Health (U.K.) Ltd

Report Scope:

In this report, the Global At-Home Drug of Abuse Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

At-Home Drug of Abuse Testing Market, By Sample Type:

• Urine Test
• Saliva Test
• Blood test
• Others

At-Home Drug of Abuse Testing Market, By Product Type:

• Drug Testing Kit
• Strips/Dip Cards
• Cassettes
• Cups
• Others

At-Home Drug of Abuse Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global At-Home Drug of Abuse Testing Market.

Available Customizations:

Global At-Home Drug of Abuse Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global At-Home Drug of Abuse Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 5.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Sample Type
• 5.3.2 By Product Type
• 5.3.3 By Region

6. North America At-Home Drug of Abuse Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 6.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States At-Home Drug of Abuse Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Sample Type
      • 6.3.1.2.2. By Product Type
  • 6.3.2. Canada At-Home Drug of Abuse Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Sample Type
      • 6.3.2.2.2. By Product Type
  • 6.3.3. Mexico At-Home Drug of Abuse Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Sample Type
      • 6.3.3.2.2. By Product Type

7. Europe At-Home Drug of Abuse Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 7.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France At-Home Drug of Abuse Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Sample Type
      • 7.3.1.2.2. By Product Type
  • 7.3.2. Germany At-Home Drug of Abuse Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Sample Type
      • 7.3.2.2.2. By Product Type
  • 7.3.3. United Kingdom At-Home Drug of Abuse Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Sample Type
      • 7.3.3.2.2. By Product Type
  • 7.3.4. Italy At-Home Drug of Abuse Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Sample Type
      • 7.3.4.2.2. By Product Type
  • 7.3.5. Spain At-Home Drug of Abuse Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Sample Type
      • 7.3.5.2.2. By Product Type

8. Asia-Pacific At-Home Drug of Abuse Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 8.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China At-Home Drug of Abuse Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Sample Type
      • 8.3.1.2.2. By Product Type
  • 8.3.2. India At-Home Drug of Abuse Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Sample Type
      • 8.3.2.2.2. By Product Type
  • 8.3.3. Japan At-Home Drug of Abuse Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Sample Type
      • 8.3.3.2.2. By Product Type
  • 8.3.4. South Korea At-Home Drug of Abuse Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Sample Type
      • 8.3.4.2.2. By Product Type
  • 8.3.5. Australia At-Home Drug of Abuse Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Sample Type
      • 8.3.5.2.2. By Product Type

9. South America At-Home Drug of Abuse Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 9.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil At-Home Drug of Abuse Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Sample Type
      • 9.3.1.2.2. By Product Type
  • 9.3.2. Argentina At-Home Drug of Abuse Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Sample Type
      • 9.3.2.2.2. By Product Type
  • 9.3.3. Colombia At-Home Drug of Abuse Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Sample Type
      • 9.3.3.2.2. By Product Type

10. Middle East and Africa At-Home Drug of Abuse Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 10.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa At-Home Drug of Abuse Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Sample Type
      • 10.3.1.2.2. By Product Type
  • 10.3.2. Saudi Arabia At-Home Drug of Abuse Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Sample Type
      • 10.3.2.2.2. By Product Type
  • 10.3.3. UAE At-Home Drug of Abuse Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Sample Type
      • 10.3.3.2.2. By Product Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global At-Home Drug of Abuse Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Dragerwerk AG & Co. KGaA.
• 15.3. UCP Biosciences Inc.
• 15.4. Orient New Life Medical Co. Ltd.
• 15.5. Assure Tech. (Hangzhou) Co., LTD
• 15.6. Psychemedics Corporation
• 15.7. Confirm Biosciences Inc
• 15.8. Pharmatech Inc.
• 15.9. Atlas Medical GmbH
• 15.10. Home Health (U.K.) Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer